Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.
Clinical trial NCT05753826 · RECRUITING
Trial details
- NCT number
- NCT05753826
- Sponsor
- Fujian Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-12-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.